Antidepressant and antipsychotic agents.
Numerous studies have been reviewed concerning the relationship of the catecholamines and indoleamines to depression and its treatment with antidepressant drugs. The profusion of data on the subject suggests the amines may be implicated in the disease, however no convincing hypothesis is available which unites the two. A similar situation seems to exist concerning the antipsychotic agents, dopamine and schizophrenia. The evidence appears to be overwhelming relating dopamine in the action of these agents and yet serious inconsistencies have been reported suggesting the need for a revision of the hypothesis regarding the mode of action of antipsychotic agents.
D000928:Antidepressive Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D001921:Brain / Q000502:physiology / Q000503:physiopathology; D002395:Catecholamines / Q000502:physiology; D003863:Depression / Q000503:physiopathology; D004723:Endorphins / Q000502:physiology; D006801:Humans; D009638:Norepinephrine / Q000502:physiology; D011942:Receptors, Adrenergic, alpha / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D013329:Structure-Activity Relationship
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002395:Catecholamines; D004723:Endorphins; D011942:Receptors, Adrenergic, alpha; D012701:Serotonin; D009638:Norepinephrine